

          1. Severe co-morbidity with life expectancy <3 months according to investigators
             assessment

          2. (Aspartate Transaminase/ Alanine Aminotransferase) ASAT/ALAT > 5 times the upper limit
             of normal

          3. Acute co-morbidity within 7 days before inclusion such as myocardial infarction

          4. Known intolerance to the available study drugs

          5. Pregnancy, possible pregnancy or breast feeding

          6. Any reason why, in the opinion of the investigators, the patient should not
             participate

          7. Subject participates in a potentially confounding drug or device trial during the
             course of the study

          8. Prolonged QT interval (>450 ms)
      